MHRA approves Xevudy (sotrovimab), a COVID-19 treatment found to cut hospitalisation and death by 79% Tags:United Kingdom 2 comments MSM won’t want this. They’ve monetised flu season and want the testing and mayhem to continue forever Excellent news, and rapid work getting it safety-qualified already! I wonder when and where it’ll be rolled out, and to whom. Leave a ReplyYou must be logged in to post a comment.
MSM won’t want this. They’ve monetised flu season and want the testing and mayhem to continue forever
Excellent news, and rapid work getting it safety-qualified already! I wonder when and where it’ll be rolled out, and to whom.
2 comments
MSM won’t want this.
They’ve monetised flu season and want the testing and mayhem to continue forever
Excellent news, and rapid work getting it safety-qualified already! I wonder when and where it’ll be rolled out, and to whom.